Table 1.
The clinical information of the ICPP and healthy girls.
| Characteristics | Control (N = 23) | ICPP (N = 25) | p-value |
|---|---|---|---|
| Age (mean ± SD, year) | 8.462 ± 2.288 | 7.045 ± 1.08 | 0.024 |
| BMI (mean ± SD, Kg/cm2) | 16.733 ± 2.306 | 16.296 ± 1.865 | 0.574 |
| FSH (mean ± SD, IU/L) | NA | 18.085 ± 5.945 | |
| LH (mean ± SD, IU/L) | NA | 9.304 ± 4.588 | |
| E2 (mean ± SD, pg/mL) | NA | 26.28 ± 15.805 | |
| TESTO (mean ± SD, ug/L) | NA | 0.259 ± 0.236 | |
| HCG (mean ± SD, IU/L) | NA | 0.462 ± 0.856 | |
| IR (mean ± SD) | NA | 7.583 ± 2.761 | |
| IGF-1 (mean ± SD, ng/mL) | NA | 199 ± 88.795 | |
| Bone Age (mean ± SD, year) | NA | 8.442 ± 1.772 |
BMI, Body mass index; FSH, Follicle stimulating hormone; LH, Luteinizing hormone; E2, Estradiol; TESTO, Testosterone; HCG, Human Chorionic Gonadotropin; IR, Insulin Resistance; IGF-1, Insulin-like growth factor 1.